[go: up one dir, main page]

AR102614A1 - HEPATITIS D VIRUS (HDV) RNAi COMPOSITIONS AND METHODS FOR USE - Google Patents

HEPATITIS D VIRUS (HDV) RNAi COMPOSITIONS AND METHODS FOR USE

Info

Publication number
AR102614A1
AR102614A1 ARP150103667A ARP150103667A AR102614A1 AR 102614 A1 AR102614 A1 AR 102614A1 AR P150103667 A ARP150103667 A AR P150103667A AR P150103667 A ARP150103667 A AR P150103667A AR 102614 A1 AR102614 A1 AR 102614A1
Authority
AR
Argentina
Prior art keywords
hdv
methods
hepatitis
virus
rnai compositions
Prior art date
Application number
ARP150103667A
Other languages
Spanish (es)
Inventor
Sepp-Lorenzino Laura
G Rajeev Kallanthottathil
Shulga-Morskaya Svetlana
Milstein Stuart
Manoharan Muthiah
Maier Martin
Jadhav Vasant
Hinkle Gregory
Xu Huilei
Original Assignee
Alnylam Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alnylam Pharmaceuticals Inc filed Critical Alnylam Pharmaceuticals Inc
Publication of AR102614A1 publication Critical patent/AR102614A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente se relaciona con agentes de ARNi, por ejemplo, agentes de ARNi de doble hebra, contra el genoma del virus de la hepatitis D (HDV), y con métodos para usar dichos agentes de ARNi para inhibir la expresión de uno o más genes de HBV, y con métodos para tratar a sujetos que tienen una infección con HDV y/o trastorno asociado con HDV.This is related to RNAi agents, for example, double-stranded RNAi agents, against the hepatitis D virus (HDV) genome, and with methods for using said RNAi agents to inhibit the expression of one or more genes. of HBV, and with methods to treat subjects who have an infection with HDV and / or disorder associated with HDV.

ARP150103667A 2014-11-10 2015-11-10 HEPATITIS D VIRUS (HDV) RNAi COMPOSITIONS AND METHODS FOR USE AR102614A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462077672P 2014-11-10 2014-11-10

Publications (1)

Publication Number Publication Date
AR102614A1 true AR102614A1 (en) 2017-03-15

Family

ID=58688516

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP150103666A AR102613A1 (en) 2014-11-10 2015-11-10 HEPATITIS B (HBV) VIRUS RNAi COMPOSITIONS AND METHODS FOR USE
ARP150103667A AR102614A1 (en) 2014-11-10 2015-11-10 HEPATITIS D VIRUS (HDV) RNAi COMPOSITIONS AND METHODS FOR USE

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP150103666A AR102613A1 (en) 2014-11-10 2015-11-10 HEPATITIS B (HBV) VIRUS RNAi COMPOSITIONS AND METHODS FOR USE

Country Status (1)

Country Link
AR (2) AR102613A1 (en)

Also Published As

Publication number Publication date
AR102613A1 (en) 2017-03-15

Similar Documents

Publication Publication Date Title
MX421406B (en) Interfering ribonucleic acid (RNAi) compositions against hepatitis B virus (HBV) and methods of use thereof
AR114551A1 (en) COMPOSITIONS OF hdRNA AGENTS AGAINST HEPATITIS B VIRUS (HBV) AND METHODS FOR THEIR USE
CL2017002230A1 (en) Combined treatment with a tlr7 agonist and inhibitor of vhb capsid assembly.
CR20170174A (en) COMPOSITIONS AND METHODS FOR THE SILENCING OF HEPATITIS B VIRUS TECHNICAL EXPRESSION
CL2019001433A1 (en) Modulators of the core protein of hepatitis b. (divisional request 201800684)
CO2019002017A2 (en) Agents of iarn for infection caused by hepatitis b virus
UY37252A (en) COMPOUNDS FOR HEPATITIS B VIRUS INFECTION TREATMENT
UY37581A (en) COMPOUNDS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION
UY35582A (en) COMPOSITIONS OF ARNi DE SERPINA1 AND ITS METHODS OF USE
CL2016002269A1 (en) Allosteric modulators of the hepatitis core protein b.
MX2016009337A (en) DERIVATIVES OF AZEPANO AND METHODS TO TREAT INFECTIONS BY HEPATITIS B.
HRP20190352T1 (en) NEW 6-CONDENSED HETEROaryldihydropropyrimidines for the Treatment and Prophylaxis of Hepatitis B Virus Infection
CL2016000493A1 (en) Hcv polymerase inhibitors
MX382900B (en) INTERFERENCE RIBONUCLEIC ACID (RNAi) COMPOSITIONS AGAINST THE COMPLEMENT COMPONENT AND METHODS FOR THEIR USE.
UY35583A (en) COMPOSITIONS OF ARNi AGAINST TMPRSS6 AND METHODS FOR USE
BR112018009009A2 (en) combined therapy of an hbv capsid formation inhibitor and an interferon
MX381896B (en) THIAZOLIDE COMPOUNDS FOR THE TREATMENT OF VIRAL INFECTIONS.
MX2019002678A (en) Combined treatment with a tlr7 agonist and an hbv capsid assembly inhibitor.
DOP2016000336A (en) ISOINDOLIN DERIVATIVES FOR USE IN THE TREATMENT OF A VIRAL INFECTION
CR20160178A (en) DEOXINOJIRIMICINE DERIVATIVES AND THEIR METHODS OF USE
MX377211B (en) THERAPEUTIC COMPOSITIONS FOR USE IN THE TREATMENT OF CANCER.
CL2018001946A1 (en) Attenuated viruses of infectious bronchitis.
MX2018004542A (en) Viral neoepitopes and uses thereof.
CL2017001595A1 (en) Vaccine compositions for dengue virus and methods of use thereof
AR102614A1 (en) HEPATITIS D VIRUS (HDV) RNAi COMPOSITIONS AND METHODS FOR USE

Legal Events

Date Code Title Description
FB Suspension of granting procedure